Kayne Anderson Rudnick Investment Management LLC Bicycle Therapeutics PLC Transaction History

Kayne Anderson Rudnick Investment Management LLC

$39.8 Billion
Q2 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$12.95 - $46.99 $388 - $1,409	-30 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $1,203 - $1,785	30 New	30 $1,000

Others Institutions Holding BCYC

# of Institutions

113

Shares Held

41.9M

Call Options Held

111K

Put Options Held

16.6K

Baker Bros. Advisors LP New York, NY

10.9M
Shares

$78.6 Million
0.77% of portfolio
Fcpm Iii Services B.V. Naarden, P7

3.45M
Shares

$24.9 Million
6.5% of portfolio
Armistice Capital, LLC New York, NY

2.8M
Shares

$20.2 Million
0.34% of portfolio
Westfield Capital Management CO LP Boston, MA

2.66M
Shares

$19.2 Million
0.12% of portfolio
Siren, L.L.C. New York, NY

2.01M
Shares

$14.5 Million
0.72% of portfolio

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $214M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account